UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV). The UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) seeks to replicate twice the monthly performance of the Solactive US High Dividend Low Volatility Index. Market cap: 0, Sector: Unknown.
Last analyzed: Mar 15, 2026UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) Business Overview & Investment Profile
UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) offers a leveraged exposure to a basket of 40 high-dividend, low-volatility U.S. stocks. The ETN aims to magnify monthly returns of the Solactive index, targeting investors seeking enhanced income and capital appreciation through a leveraged strategy.
Investment Thesis
HDLV offers a leveraged play on high-dividend, low-volatility U.S. equities. A key value driver is the potential for magnified returns in a rising market for dividend-paying stocks. However, the 2x leverage also amplifies losses, making it a high-risk investment. The performance is directly linked to the Solactive US High Dividend Low Volatility Index. Catalysts include favorable market conditions for high-dividend stocks and effective index management. Risks include the potential for significant losses in a declining market, the costs associated with leverage, and the credit risk associated with UBS. Investors should carefully consider their risk tolerance and investment objectives before investing in HDLV.
Based on FMP financials and quantitative analysis
Key Highlights
- HDLV provides a 2x leveraged exposure to the Solactive US High Dividend Low Volatility Index.
- The Solactive index tracks 40 U.S.-listed stocks with high dividend yields and relatively low volatility.
- HDLV's performance is subject to fees and expenses, which can impact returns.
- As an ETN, HDLV carries credit risk associated with UBS.
- HDLV does not pay a dividend.
Strengths
- Leveraged exposure to high-dividend, low-volatility stocks.
- Tracks a well-defined index.
- Potential for enhanced returns in a favorable market environment.
Weaknesses
- Leverage amplifies losses.
- Subject to fees and expenses.
- Carries credit risk associated with UBS.
Catalysts
- Ongoing: Favorable market conditions for high-dividend, low-volatility stocks.
- Ongoing: Strategic index management by Solactive.
- Ongoing: Increased investor demand for income-generating assets.
Risks
- Potential: Market downturns can lead to significant losses due to leverage.
- Potential: Changes in interest rates can impact the attractiveness of dividend stocks.
- Potential: Credit risk associated with UBS.
- Ongoing: Fees and expenses can reduce overall returns.
Growth Opportunities
- Increased Investor Demand for Income: As interest rates remain low, investors may seek higher income through dividend-paying stocks, potentially driving demand for HDLV. The market for dividend-focused investments is substantial, with trillions of dollars invested in dividend ETFs and mutual funds. Timeline: Ongoing.
- Growing Popularity of Leveraged Products: The increasing acceptance and understanding of leveraged ETFs and ETNs among sophisticated investors could lead to greater adoption of HDLV. The leveraged ETF market has grown significantly in recent years, indicating a growing appetite for these products. Timeline: Ongoing.
- Favorable Market Conditions for High-Dividend Stocks: If market conditions favor high-dividend, low-volatility stocks, HDLV could benefit from increased investor interest and positive performance. A rising market for dividend stocks would amplify the returns of HDLV due to its 2x leverage. Timeline: Ongoing.
- Strategic Index Management: Effective management of the Solactive US High Dividend Low Volatility Index, including timely rebalancing and stock selection, can enhance HDLV's performance and attract investors. A well-managed index can outperform its peers, leading to greater investor confidence in HDLV. Timeline: Ongoing.
- Expansion of Distribution Channels: UBS could expand the distribution channels for HDLV, making it more accessible to a wider range of investors. Increased availability through brokerage platforms and financial advisors could drive demand for HDLV. Timeline: Ongoing.
Opportunities
- Increased investor demand for income.
- Growing popularity of leveraged products.
- Favorable market conditions for high-dividend stocks.
Threats
- Market downturns can lead to significant losses.
- Changes in interest rates can impact the attractiveness of dividend stocks.
- Increased competition from other leveraged ETFs and ETNs.
Competitive Advantages
- Leveraged Exposure: Offers a unique 2x leveraged exposure to a specific index.
- High-Dividend, Low-Volatility Focus: Targets a specific segment of the market with a focus on dividend-paying stocks with lower volatility.
- Established Index: Tracks the Solactive US High Dividend Low Volatility Index, providing a transparent and rules-based approach.
About HDLV
The UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) is an exchange-traded note designed to provide investors with a leveraged return based on the performance of the Solactive US High Dividend Low Volatility Index. This index comprises 40 U.S.-listed stocks selected from the top 1,000 by market capitalization, focusing on companies that exhibit both high dividend yields and relatively low price volatility. The ETN employs a 2x leverage factor, meaning it aims to deliver twice the monthly percentage change of the underlying index, subject to certain fees and expenses. Launched to cater to investors seeking enhanced returns and income, HDLV offers a way to potentially amplify gains from dividend-focused equities. However, the leveraged nature of the ETN also magnifies potential losses, making it a higher-risk investment suitable for sophisticated investors with a thorough understanding of leveraged products. The ETN's performance is directly tied to the Solactive index, which is rebalanced periodically to maintain its focus on high-dividend, low-volatility stocks. The ETN is subject to credit risk, as it is an obligation of UBS and its value depends on UBS's ability to meet its obligations. The ETN does not pay a dividend.
What They Do
- Provides leveraged exposure to the Solactive US High Dividend Low Volatility Index.
- Tracks the performance of 40 U.S.-listed stocks with high dividend yields and relatively low volatility.
- Offers a 2x leveraged return, aiming to double the monthly percentage change of the index.
- Subject to fees and expenses, which can impact returns.
- Carries credit risk associated with UBS.
- Does not pay a dividend.
Business Model
- HDLV generates revenue through fees and expenses charged to investors.
- The ETN's performance is linked to the Solactive US High Dividend Low Volatility Index.
- UBS acts as the issuer of the ETN, assuming the credit risk.
Industry Context
HDLV operates within the exchange-traded products (ETP) market, specifically focusing on leveraged and dividend-focused strategies. The ETP market has seen significant growth in recent years, driven by increasing investor demand for specialized investment products. HDLV competes with other leveraged ETFs and ETNs that target dividend-paying stocks. The performance of HDLV is heavily influenced by market trends affecting high-dividend, low-volatility equities. The competitive landscape includes both leveraged and unleveraged dividend ETFs, requiring HDLV to differentiate itself through its specific index and leverage factor.
Key Customers
- Sophisticated investors seeking leveraged exposure to high-dividend, low-volatility stocks.
- Investors looking for enhanced returns and income potential.
- Investors with a high-risk tolerance and a thorough understanding of leveraged products.
Financials
Chart & Info
UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) stock price: Price data unavailable
Latest News
No recent news available for HDLV.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HDLV.
Price Targets
Wall Street price target analysis for HDLV.
MoonshotScore
What does this score mean?
The MoonshotScore rates HDLV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry UnknownHDLV Unknown Stock FAQ
What does UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN do?
HDLV is an exchange-traded note that seeks to deliver twice the monthly performance of the Solactive US High Dividend Low Volatility Index. This index tracks 40 U.S.-listed companies selected from the largest 1,000 by market capitalization, focusing on those with high dividend yields and relatively low price volatility. The ETN provides investors with a leveraged way to gain exposure to these dividend-paying stocks, aiming to amplify their returns, but also their losses.
What do analysts say about HDLV stock?
As an ETN, HDLV's performance is directly tied to the Solactive US High Dividend Low Volatility Index and the creditworthiness of UBS. Analysts typically focus on the index's composition, the performance of its constituent stocks, and the overall market environment for dividend-paying equities. Key valuation metrics include the index's dividend yield, volatility, and the expense ratio of the ETN. Growth considerations center on the potential for increased investor demand for income-generating assets and the effectiveness of the index's stock selection process. No buy/sell recommendations can be made.
What are the main risks for HDLV?
The primary risk for HDLV is the leveraged nature of the ETN, which amplifies both gains and losses. A market downturn or a decline in the value of the underlying index could result in significant losses for investors. Additionally, HDLV carries credit risk associated with UBS, as the ETN is an obligation of the issuer. Changes in interest rates and increased competition from other leveraged ETFs and ETNs also pose potential risks. Investors should carefully consider their risk tolerance and investment objectives before investing in HDLV.
What are the key factors to evaluate for HDLV?
Evaluating HDLV involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Leveraged exposure to high-dividend, low-volatility stocks.. Primary risk to monitor: Potential: Market downturns can lead to significant losses due to leverage.. This is not financial advice.
How frequently does HDLV data refresh on this page?
HDLV prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HDLV's recent stock price performance?
Recent price movement in UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Leveraged exposure to high-dividend, low-volatility stocks.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HDLV overvalued or undervalued right now?
Determining whether UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HDLV?
Before investing in UBS ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN (HDLV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- Investment decisions should be made after consulting with a qualified financial advisor.